Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTAMedical - Care Facilities
+$0.00 today
- Market cap
- $445.55M
- Beta
- 0.00
- P/E (TTM)
- 414.6
- EPS (TTM)
- $0.07
Volume 0.00M
Average 0.87M
MCTA Deferred Revenue
Payments received for goods or services the company will deliver within the next year.
Charming Medical Limited Class A Ordinary SharesNASDAQ: MCTA
Deferred Revenue · Q4 FY2024 · quarter ended Mar 2025
Deferred revenue falls 23.0% from a year ago
Deferred revenue stood at $3.46M at the end of Q4 FY2024, down 23.0% from a year earlier.
Context
- Deferred revenue amounted to 64.7% of total assets at the end of Q4 FY2024, down 27.4 pp from a year earlier.
- Deferred revenue increased in 0 of the last 2 fiscal years.
- FY2024 was the lowest annual figure in the 3 fiscal years shown.
What to watch
Whether deferred revenue keeps falling in the next quarterly balance sheet after a -23.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Deferred Revenue history
USD · from the balance sheet
- Latest · FY2024
- 3.46M USD
- Year-over-year change
- -23.0%
- 2-year CAGR
- -21.4%
| Period | Period end | Deferred Revenue | YoY change |
|---|---|---|---|
| FY2024 | 2025-03-31 | 3.46M | -23.0% |
| FY2023 | 2024-03-31 | 4.5M | -19.7% |
| FY2022 | 2023-03-31 | 5.6M | — |
Deferred Revenue vs competitors
How MCTA compares with its peers on the latest reported figures
- MCTA's Mar 2025 deferred revenue of $3.46M is the 3rd highest of the 10 companies compared; the peer median is $0.
- Its year-over-year change of -23.0% is the 3rd highest of 4, against a peer median of +65.3%.
- Deferred revenue amounts to 64.7% of total assets for MCTA, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $23.12M | +1284233.3% | — | 3.7% | |
| Feb 2026 | $5.53M | +65.3% | -2.0% | 3.8% | |
MCTACharming Medical Limited Class A Ordinary Shares | Mar 2025 | $3.46M | -23.0% | — | 64.7% |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | -100.0% | +26.1% | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | +38.7% | 0.0% | |
| Peer median (excluding MCTA) | $0 | +65.3% | +26.1% | 0.0% | |
Competitors are the stored peer set for MCTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTA
Intrinsic Alpha fair value
Locked
Current Price
$29.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.